The clinical and molecular epidemiology of pre-transplant vancomycin-resistant enterococci colonization among liver transplant recipients

Clinical Transplantation

Volumn 30, Issue 3, 2016, Pages 306-311

  Banach, David B ^a   Peaper, David R ^a   Fortune, Brett E ^b   Emre, Sukru ^b   Dembry, Louise M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Yale New Haven Transplantation Center   (United States)

Author keywords

Active surveillance; Liver transplantation; Multidrug resistant organisms; Vancomycin resistant enterococci

Indexed keywords

CEPHALOSPORIN DERIVATIVE; DAPTOMYCIN; QUINOLONE DERIVATIVE; RIFAXIMIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ABDOMINAL COMPARTMENT SYNDROME; ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; BRAIN HEMORRHAGE; CANDIDEMIA; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CENTRAL VENOUS CATHETERIZATION; COHORT ANALYSIS; CONTROLLED STUDY; DAY HOSPITAL; DESCRIPTIVE RESEARCH; DISEASE SURVEILLANCE; ENTEROCOCCAL INFECTION; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; INFECTION PREVENTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MICROBIAL DIVERSITY; MOLECULAR EPIDEMIOLOGY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REPEAT PROCEDURE; REPETITIVE SEQUENCE BASED POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; SURGICAL INFECTION; URINARY TRACT INFECTION; VANCOMYCIN RESISTANT ENTEROCOCCUS; ADVERSE EFFECTS; ANTIBIOTIC RESISTANCE; CONNECTICUT; DRUG EFFECTS; ENTEROCOCCUS; FOLLOW UP; GRAM-POSITIVE BACTERIAL INFECTIONS; ISOLATION AND PURIFICATION; LIVER DISEASES; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RISK FACTOR;

ANTI-BACTERIAL AGENTS; CONNECTICUT; ENTEROCOCCUS; FEMALE; FOLLOW-UP STUDIES; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 84959261276     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12690     Document Type: Article

References (19)

1. Papanicolaou GA, Meyers BR, Meyers J et al. Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality. Clin Infect Dis 1996: 23: 760.
2. Patel R, Allen SL, Manahan JM et al. Natural history of vancomycin-resistant enterococcal colonization in liver and kidney transplant recipients. Liver Transpl 2001: 7: 27
3. Gearhart M, Martin J, Rudich S et al. Consequences of vancomycin-resistant Enterococcus in liver transplant recipients: a matched control study. Clin Transplant 2005: 19: 711.
4. Russell DL, Flood A, Zaroda TE et al. Outcomes of colonization with MRSA and VRE among liver transplant candidates and recipients. Am J Transplant 2008: 8: 1737.
5. Newell KA, Millis JM, Arnow PM et al. Incidence and outcome of infection by vancomycin-resistant Enterococcus following orthotopic liver transplantation. Transplantation 1998: 65: 439.
6. Slaughter S, Hayden MK, Nathan C et al. A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med 1996: 125: 448.
7. Hagen EA, Lautenbach E, Olthoff K, Blumberg EA. Low prevalence of colonization with vancomycin-resistant Enterococcus in patients awaiting liver transplantation. Am J Transplant 2003: 3: 902.
8. Mlynarczyk A, Szymanek-Majchrzak K, Kosykowska E et al. The dominant sequence types of vancomycin-resistant Enterococcus faecium among transplantation ward patients. Transplant Proc 2011: 43: 3132.
9. Karden-Lilja M, Vuopio J, Koskela M, Tissari P, Salmenlinna S. Molecular typing of vancomycin-resistant Enterococcus faecium with an automated repetitive sequence-based PCR microbial typing system compared with pulsed-field gel electrophoresis and multilocus sequence typing. Scand J Infect Dis 2013: 45: 350.
10. de Gouvea EF, Castelo Branco R, Monteiro RC et al. Surveillance for vancomycin-resistant enterococci colonization among patients of a liver transplant program. Transpl Int 2005: 18: 1218.
11. Freitas MC, Pacheco-Silva A, Barbosa D et al. Prevalence of vancomycin-resistant Enterococcus fecal colonization among kidney transplant patients. BMC Infect Dis 2006: 6: 133.
12. Tornieporth NG, Roberts RB, John J, Hafner A, Riley LW. Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients. Clin Infect Dis 1996: 23: 767.
13. Carmeli Y, Eliopoulos GM, Samore MH. Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus. Emerg Infect Dis 2002: 8: 802.
14. Almyroudis NG, Lesse AJ, Hahn T et al. Molecular epidemiology and risk factors for colonization by vancomycin-resistant Enterococcus in patients with hematologic malignancies. Infect Control Hosp Epidemiol 2011: 32: 490.
15. D'Agata EM, Green WK, Schulman G, Li H, Tang YW, Schaffner W. Vancomycin-resistant enterococci among chronic hemodialysis patients: a prospective study of acquisition. Clin Infect Dis 2001: 32: 23.
16. Al-Nassir WN, Sethi AK, Li Y, Pultz MJ, Riggs MM, Donskey CJ. Both oral metronidazole and oral vancomycin promote persistent overgrowth of vancomycin-resistant enterococci during treatment of Clostridium difficile-associated disease. Antimicrob Agents Chemother 2008: 52: 2403.
17. McNeil SA, Malani PN, Chenoweth CE et al. Vancomycin-resistant enterococcal colonization and infection in liver transplant candidates and recipients: a prospective surveillance study. Clin Infect Dis 2006: 42: 195.
18. Ziakas PD, Pliakos EE, Zervou FN, Knoll BM, Rice LB, Mylonakis E. MRSA and VRE colonization in solid organ transplantation: a meta-analysis of published studies. Am J Transplant 2014: 14: 1887.
19. Bratzler DW, Dellinger EP, Olsen KM et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect 2013: 14: 73.